Its mechanism of action against atherosclerosis is closely associated with the targeted negative regulation of TLR4 through increased miR-140 expression, and the suppression of TLR4/NF-κB/VEGF signaling pathway activation. The gene discussed is NFKB1; the disease is atherosclerosis.